Injectable PLGA microspheres encapsulating WKYMVM peptide for neovascularization.

[1]  Junho Chung,et al.  A novel delivery platform for therapeutic peptides. , 2014, Biochemical and biophysical research communications.

[2]  J. H. Kim,et al.  WKYMVm‐Induced Activation of Formyl Peptide Receptor 2 Stimulates Ischemic Neovasculogenesis by Promoting Homing of Endothelial Colony‐Forming Cells , 2014, Stem cells.

[3]  A. Józkowicz,et al.  Therapeutic angiogenesis for revascularization in peripheral artery disease. , 2013, Gene.

[4]  R. Ammendola,et al.  Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists , 2013, International journal of molecular sciences.

[5]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  G. Fu,et al.  Endothelial Progenitor Cells: Current Development of Their Paracrine Factors in Cardiovascular Therapy , 2012, Journal of cardiovascular pharmacology.

[7]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. , 2011, Polymers.

[8]  Yun Zhang,et al.  ptx3, a key component of innate immunity, is induced by saa via fprl1‐mediated signaling in HAECs , 2011, Journal of cellular biochemistry.

[9]  S. Ryu,et al.  The Agonists of Formyl Peptide Receptors Prevent Development of Severe Sepsis after Microbial Infection , 2010, The Journal of Immunology.

[10]  Marilena Loizidou,et al.  Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.

[11]  M. Harmsen,et al.  Endothelial progenitor cell-based neovascularization: implications for therapy. , 2009, Trends in molecular medicine.

[12]  Qingbo Xu,et al.  Vascular repair by endothelial progenitor cells. , 2008, Cardiovascular research.

[13]  C. Liang,et al.  In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.

[14]  S. Ryu,et al.  Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis1 , 2006, The Journal of Immunology.

[15]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[16]  M. Yoder,et al.  Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. , 2005, Blood.

[17]  N. Caplice,et al.  Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. , 2005, Stem cells and development.

[18]  W. Schaper,et al.  Influence of Mechanical, Cellular, and Molecular Factors on Collateral Artery Growth (Arteriogenesis) , 2004, Circulation research.

[19]  Thomas Schmitz-Rixen,et al.  Elevated Fluid Shear Stress Enhances Postocclusive Collateral Artery Growth and Gene Expression in the Pig Hind Limb , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[20]  T. Kissel,et al.  In situ forming parenteral drug delivery systems: an overview. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  J. Oppenheim,et al.  Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes1 , 2004, The Journal of Immunology.

[22]  J. Kwak,et al.  Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling1 , 2004, The Journal of Immunology.

[23]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[24]  C. Heeschen,et al.  Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. , 2003, Blood.

[25]  D. Federman,et al.  Peripheral Arterial Disease , 2018, Contemporary Cardiology.

[26]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[27]  S. Zahler,et al.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.

[28]  I. Williams,et al.  Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. , 2003, American journal of physiology. Cell physiology.

[29]  Philip M Murphy,et al.  Formyl-peptide receptors revisited. , 2002, Trends in immunology.

[30]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[31]  C. Dahlgren,et al.  The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2* , 2001, The Journal of Biological Chemistry.

[32]  S. Rafii,et al.  Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells , 2001, The Journal of experimental medicine.

[33]  J. Waltenberger.  Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. , 2001, Cardiovascular research.

[34]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[35]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[36]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. Gong,et al.  Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. , 1999, Journal of immunology.

[38]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[39]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[40]  J. Isner,et al.  Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. , 1997, Circulation.

[41]  O'donnell,et al.  Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.

[42]  S. Ryu,et al.  A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. , 1997, Journal of immunology.

[43]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[44]  S. Ryu,et al.  Identification of the Peptides That Stimulate the Phosphoinositide Hydrolysis in Lymphocyte Cell Lines from Peptide Libraries (*) , 1996, The Journal of Biological Chemistry.

[45]  D. Pettit,et al.  Biodegradable polymers for protein and peptide drug delivery. , 1995, Bioconjugate chemistry.

[46]  Nikolaos A. Peppas,et al.  Novel preparation of poly (vinyl alcohol) microparticles without crosslinking agent for controlled drug delivery of proteins , 1993 .

[47]  I. Sjöholm,et al.  Interferon-γ in Starch Microparticles: Nitric Oxide-Generating Activity in Vitro and Antileishmanial Effect in Mice , 1993, Pharmaceutical Research.

[48]  M. Goosen,et al.  Optimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreas , 1985, Biotechnology and bioengineering.

[49]  Jun-Lin Guan,et al.  Wound-healing assay. , 2005, Methods in molecular biology.

[50]  J. Alroy,et al.  Lectin histochemistry of mammalian endothelium , 2004, Histochemistry.

[51]  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use , 2002 .

[52]  S. Rafii,et al.  Circulating endothelial precursors: mystery, reality, and promise. , 2000, The Journal of clinical investigation.

[53]  H. Boudier.  Arteriolar and capillary remodelling in hypertension. , 1999, Drugs.